Corneal collagen cross-linking for infectious keratitis: an update of clinical studies
Publication in refereed journal

Times Cited
Web of Science17WOS source URL (as at 20/02/2021) Click here for the latest count
Altmetrics Information

Other information
AbstractCollagen cross-linking (CXL) with ultraviolet light-activated riboflavin is a corneal surface procedure developed for the treatment of keratoconus and corneal ectasia. With the known microbicidal and corneal stiffening effects of ultraviolet irradiation and photoactivated riboflavin, it has recently been introduced for the management of infectious keratitis, especially for ulcers resistant to antimicrobial therapy or associated with corneal melting. Various authors have attempted to use CXL as an adjunctive, salvage or even as the sole treatment for infectious corneal ulcers. The aim of this review was to provide a summary of the clinical studies in the literature. It is worth noting that there is still no consensus on the treatment protocol of CXL against infectious keratitis. The disparities in outcome measures, treatment protocol and study design can confound the interpretation and hamper the generalization of the study results. Based on current evidence, the role of CXL in infectious keratitis remained unclear despite the reported success in some clinical cases. Further investigations are warranted concerning the efficacy and safety of treating infectious keratitis with CXL.
All Author(s) ListChan TCY, Lau TWS, Lee JWY, Wong IYH, Jhanji V, Wong RLM
Journal nameActa Ophthalmologica
Volume Number93
Issue Number8
Pages689 - 696
LanguagesEnglish-United Kingdom
Keywordscollagen cross-linking; corneal melting; infectious keratitis; photodynamic therapy; riboflavin; ulcer
Web of Science Subject CategoriesOphthalmology

Last updated on 2021-21-02 at 01:09